Status:
COMPLETED
The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer
Lead Sponsor:
Lund University
Collaborating Sponsors:
Swedish Cancer Foundation
ALF Swedish Government Grant
Conditions:
Prostate Cancer Recurrent
Eligibility:
MALE
20-30 years
Phase:
NA
Brief Summary
In order to elucidate if FSH can have testosterone like effects, samples from young, non-smoking healthy volunteers, with normal body mass index, and with pharmacologically induced gonadotropin defici...
Detailed Description
Normally, prostate specific antigen (PSA), which is a marker for prostate disease and progression, is exclusively produced in response to testosterone. In order to elucidate if follicle stimulating ho...
Eligibility Criteria
Inclusion
- Healthy, non-smoking, body mass index 20-25,
Exclusion
- Medication or drug abuse
- \-
Key Trial Info
Start Date :
September 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04134130
Start Date
September 16 2019
End Date
December 31 2019
Last Update
January 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Medicine Center
Malmo, Sweden, 21428